MCH (Mean Corpuscular Haemoglobin) – Definition, mechanism and clinical applications

Definition

MCH (Mean Corpuscular Haemoglobin) corresponds to the average amount of haemoglobin per red blood cell. It is expressed in picograms (pg) and it is part of the erythrocyte indices measured during a blood test. Haemoglobin is the protein responsible for the transport of oxygen from the lungs to the tissues. MCH allows indirect assessment of the capacity of each red blood cell to perform this function.

A normal value of MCH is usually between 27 and 32 pg per red blood cell, with some variation depending on laboratories and the person tested.  A low value often indicates a reduced haemoglobin content within red blood cells, characteristic of certain anaemias, while a high value may reflect abnormalities in the maturation of red blood cells. MCH is expressed in association with other parameters such as Mean Corpuscular Volume (MCV) and Mean Corpuscular Haemoglobin Concentration (MCHC), to help guide diagnosis.

Origin and context of use

MCH was introduced with the development of automated blood analysis during the 20^th century, alongside the introduction of haematology analysers capable of precisely measuring characteristic of blood cells. It is part of erythrocyte indices, used to refine the analysis of red blood cells beyond simple counting.

Its use has become widespread in routine blood tests, particularly in the investigation of anaemias. MCH helps distinguish different types of abnormalities, especially those related to impaired haemoglobin synthesis or cell maturation disorders. It is now a standard parameter, systematically reported in any complete haematologic analysis, both in general practice and hospital settings.

How does it work?

MCH is calculated from two parameters measured during blood analysis: the total concentration of haemoglobin and the red blood cells count. The formula is as follows: MCH = [haemoglobin (g/dL) / red blood cell count (millions/mm³)] x 10. This calculation estimates the average amount of haemoglobin per cell.

Physiologically, haemoglobin is synthetised in red blood cell precursors within the bone marrow. Its production depends on the availability of iron, vitamin B12 and folate. Any disruption in these elements may alter the amount of haemoglobin within each red blood cell, thereby affecting MCH.

A low MCH correspond to hypochromic red blood cells, which are poor in haemoglobin, and have a reduced capacity to transport oxygen. Conversely, a high MCH is often associated with larger red blood cells, as seen in certain macrocytic anaemias. MCH does not reflect the amount of haemoglobin within a cell, but rather the total amount, which is why it must be interpreted alongside other indices for a complete analysis.

When is it used?

MCH is mainly used in the investigation of blood abnormalities, particularly anaemias. It is relevant in the assessment of symptoms such as fatigue, pallor, shortness of breath or dizziness, which may indicate reduced oxygen transport.

It helps guide the diagnosis between different types of anaemia, a low value is frequently observed in iron-deficiency anaemia, while a high value may be associated with vitamin B12 or folate deficiency. MCH is also useful in the management of chronic diseases, assessing more complex haematological disorders, and evaluating treatment effectiveness (iron supplementation for example). It forms part of a global approach including other biological parameters.

Benefits and objectives

The value of MCH lies in its ability to refine red blood cell analysis and guide investigations:

✓ Identification of abnormalities in haemoglobin content at the cellular level

✓ Differentiation of types of anaemia according to their mechanism

✓ Contribution to a more precise diagnosis in conjunction with other indices

✓ Monitoring of disease progression or response to treatment

✓ Detection of nutritional deficiencies affecting haemoglobin production

This simple parameter, obtained without additional testing, and it provides essential information on the functional quality of red blood cells. It may help avoid more invasive investigation initially and supports rapid and reliable clinical decision-making.

Risks, limitations and controversies

MCH has limitations related to its indirect and calculated nature. It depends on the accuracy of haemoglobin measurement and red blood cell count, which may introduce bias in the case of analytical mistake. It cannot establish a diagnosis on its own, as several conditions may produce similar variations.

Some situations, such as recent transfusion or chronic diseases, may affect its interpretation. MCH does not reflect the distribution of haemoglobin among red blood cells, which may hide heterogeneous abnormalities. Its interpretation must always be part of a comprehensive analysis including clinical data and other biological parameters.

Research and innovations

Advances in automated haematology have improved the accuracy and speed of the erythrocyte indices measurement, including MCH. Modern analysers now provide more detailed data, including the distribution of haemoglobin within red blood cells.

Current research focuses on improving understanding of qualitative abnormalities of red blood cells, particularly through advanced cytometry and cellular imaging techniques. These approaches refine the interpretation of traditional indices such as MCH. Complementary biomarkers are also studied to improve the differential diagnosis of anaemias. Integration of these data into decision-support systems may enhance the clinical relevance of blood tests in the years to come.

Frequently asked questions

What does MCH mean in a blood test?

MCH corresponds to the average amount of haemoglobin contained in each red blood cell. It is part of the indices measured during a full blood count, and it helps assess red blood cell function in the transport of oxygen.

What is the normal value of MCH?

The normal range is usually between 27 and 32 picograms per red blood cell. This may vary slightly depending on laboratory, age and sex of the patient.

What does a low MCH mean?

A low MCH indicates that the red blood cells contain less haemoglobin than normal. This is commonly associated with iron-deficiency anaemia, which limit the normal production of haemoglobin.

What does a high MCH mean?

A high MCH may indicate that the red blood cells contain more haemoglobin and are often larger. This may be seen in certain anaemias related to a vitamin B12 and foliate deficiency.

Is MCH sufficient to diagnose an anaemia?

No, it is not sufficient. It must be interpreted alongside other parameters such as MCV, MCHC and total amount of haemoglobin to establish a precise diagnosis.

What is the difference between MCH and MCHC?

MCH measures the total amount of haemoglobin per red blood cell, whereas MCHC indicates the concentration of haemoglobin within a given volume of red blood cell.

Does MCH vary with age?

Yes, variation may appear with age, particularly in infants and older adults. Reference values are adapted to each age group.

Is MCH influenced by diet?

Yes, it is indirectly. Iron, vitamin B12 or foliate deficiencies can affect the synthesis of haemoglobin and alter MCH.

When is MCH measured?

MCH is automatically included in a full blood count, typically requested during routine checkups or when anaemia is suspected.

Is it possible to correct an abnormal MCH?

Yes, it is by treating the underlying cause. Iron or vitamin supplementation may normalise the MCH if a deficiency is identified.

Key points

MCH is a key index in a full blood count that reflects the average amount of haemoglobin content per red blood cell. It helps guide diagnosis of anaemias and identify nutritional deficiencies or disorders of red blood cells production. Its interpretation always relies on correlation with other biological parameters. Easily accessible, it constitutes an essential tool for assessing oxygen transport capacity in the body.

Back to Health Glossary